BE852756A - Vaccin contre la rhinotracheite virale des felides et procede pour le preparer - Google Patents

Vaccin contre la rhinotracheite virale des felides et procede pour le preparer

Info

Publication number
BE852756A
BE852756A BE176016A BE176016A BE852756A BE 852756 A BE852756 A BE 852756A BE 176016 A BE176016 A BE 176016A BE 176016 A BE176016 A BE 176016A BE 852756 A BE852756 A BE 852756A
Authority
BE
Belgium
Prior art keywords
felid
rhinotracheitis
preparing
vaccine against
against viral
Prior art date
Application number
BE176016A
Other languages
English (en)
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Publication of BE852756A publication Critical patent/BE852756A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE176016A 1976-03-30 1977-03-22 Vaccin contre la rhinotracheite virale des felides et procede pour le preparer BE852756A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/671,792 US4031204A (en) 1976-03-30 1976-03-30 Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom

Publications (1)

Publication Number Publication Date
BE852756A true BE852756A (fr) 1977-09-22

Family

ID=24695906

Family Applications (1)

Application Number Title Priority Date Filing Date
BE176016A BE852756A (fr) 1976-03-30 1977-03-22 Vaccin contre la rhinotracheite virale des felides et procede pour le preparer

Country Status (13)

Country Link
US (1) US4031204A (fr)
JP (2) JPS52120117A (fr)
AU (1) AU510744B2 (fr)
BE (1) BE852756A (fr)
CA (1) CA1085724A (fr)
DE (1) DE2713371A1 (fr)
FR (1) FR2346022A1 (fr)
GB (1) GB1580844A (fr)
IE (1) IE44911B1 (fr)
LU (1) LU77030A1 (fr)
NL (1) NL7703197A (fr)
NZ (1) NZ183618A (fr)
ZA (1) ZA771893B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
ZA796476B (en) * 1978-11-30 1981-07-29 Wellcome Found Feline infectious peritonitis vaccine
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
JPS59501161A (ja) * 1982-06-10 1984-07-05 パ−セル・ロバ−ト・エツチ 脂質ウイルスの不活性化方法
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
CA1208551A (fr) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Traitement par solvant des produits de proteines plasmatiques
CA1237668A (fr) * 1983-02-25 1988-06-07 Novagene Inc. Mutant du virus de l'herpes bovin resistant a la chaleur et negatif a la thymidine kinase utilise comme vaccin
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
US5718901A (en) * 1989-07-21 1998-02-17 Pharmacia & Upjohn Company Feline calicivirus gene
ZA927037B (en) * 1991-09-30 1993-03-29 Akzo Nv Respiratory disease vaccine for cats.
US7306807B2 (en) * 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
GB2509940A (en) * 2013-01-18 2014-07-23 John Ogino Vaccine production via irradiation of pathogenic cultures
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259546A (en) * 1962-06-01 1966-07-05 Canadian Patents Dev Treatment of viruses
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea
CA1058074A (fr) * 1974-03-25 1979-07-10 Pitman-Moore Vaccin contre la rhinotracheite des felins et mode de production

Also Published As

Publication number Publication date
IE44911L (en) 1977-09-30
JPS52120117A (en) 1977-10-08
JPS62115279A (ja) 1987-05-26
ZA771893B (en) 1978-03-29
AU2329177A (en) 1978-09-21
AU510744B2 (en) 1980-07-10
LU77030A1 (fr) 1977-07-22
GB1580844A (en) 1980-12-03
IE44911B1 (en) 1982-05-19
JPS6257307B2 (fr) 1987-11-30
CA1085724A (fr) 1980-09-16
US4031204A (en) 1977-06-21
FR2346022B1 (fr) 1981-07-10
FR2346022A1 (fr) 1977-10-28
DE2713371A1 (de) 1977-10-13
DE2713371C2 (fr) 1989-01-05
NZ183618A (en) 1979-12-11
NL7703197A (nl) 1977-10-04
JPS6216933B2 (fr) 1987-04-15

Similar Documents

Publication Publication Date Title
BE852756A (fr) Vaccin contre la rhinotracheite virale des felides et procede pour le preparer
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
DE3067376D1 (en) Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer
BE878430A (fr) Vaccins contre la pasteurellose
BE858992A (fr) Procede de preparation de vaccins
BE826568A (fr) Procede de preparation de vaccins vivants contre la varicelle
JPS5612319A (en) Cholera vaccine
BE835784A (fr) Vaccin de calicivirus des felides et procede pour le preparer
IT1156717B (it) Procedimento per ottenere vaccini acellulari potenziati
GB2053233B (en) Vaccinating cyclopeptidic antigenic fraction process for isolating it and vaccines containing it
DK340679A (da) Chlorambucilderivater og fremgangsmaade til fremstilling heraf
DK94880A (da) D-2-hydroxy-4-methylmercaptosmoersyrederivater fremgangsmaade til fremstilling heraf samt anvendelse heraf
GB2065473B (en) Process for producing hepatitis b vaccine
DK460780A (da) Pyridothienotriaziner og pyridothienotriazinoner samt fremgangsmaade til fremstilling heraf
BE855944A (fr) Procede de preparation des 1-phenyl-3-amino-pyrazoles
PT68275A (fr) Procede pour la preparation de vaccins contre les maladiesprovoquees par des paramixovirus
FR2346336A1 (fr) Procede pour preparer les 2-mercaptopyridine-1-oxydes et leurs sels
IT1098257B (it) Procedimento di preparazione di pezzi in ceramica mediante elettroforesi
NL7811447A (nl) Eiwitconcentraat en werkwijze ter bereiding daarvan.
NO156564C (no) Kompleks-salter og fremgangsmaate til fremstilling derav.
BE871586A (fr) Vaccin contre haemophilus influenzae et procede pour sa preparation
IT1111463B (it) Foglio permeabile per bustine di the e procedimento per la sua fabbricazione
JPS5491437A (en) Pasteurizing method for culture solution in solution cultivation
DK531880A (da) Fremgangsmaade til fremstilling af 3-hydrazino-6-pyridinyl-pyridaziner og syreadditionssalte heraf
JPS5651934A (en) Tea cultivating method

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NORDEN LABORATORIES INC.

Effective date: 19910331